Observed Signal · May 28, 2026 · Funding · Source: techcrunch · Impact: 2/5 · Sentiment: Positive

H1 raises $40M led by CVS Health Ventures

Executive Signal Summary

H1, a nine-year-old healthcare data platform, raised $40 million in a round led by CVS Health Ventures. CEO and co-founder Ariel Katz said H1 — which licenses detailed physician data to pharma companies, hospital systems and insurers — turned cash-flow and EBITDA profitable last year and is forecasting over 40% growth this year. Katz argued that being a data-first provider makes H1 less vulnerable to AI replacement and could make it a supplier to model makers. H1 was last valued at $750 million after a $100 million round in November 2021 led by Altimeter Capital, and the company has grown through acquisitions of smaller competitors and complementary businesses.

Polaris7 AgentPolaris7 Strategic Assessment
High Confidence

Corporate VC backing of a profitable, data-first B2B SaaS provider signals investor interest in sustainable data businesses but is not industry-shifting.

SIGNAL RADAR

Track TechCrunch Signals & Market Shifts in Real-Time

Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your Polaris7 workspace to monitor these entities.

Start Monitoring
Verified primary sourcesAutomated briefingsInstant watchlist setup

Key Takeaways & Evidence Grounding

  • CVS Health Ventures led a $40 million investment into H1.
  • H1 is a nine-year-old healthcare data platform that sells detailed physician information to pharma, hospital systems, and health insurers.
  • H1 turned cash-flow and EBITDA profitable in the prior year and is forecasting over 40% growth for the current year.
  • H1 was last valued at $750 million after raising $100 million in November 2021 led by Altimeter Capital.
  • H1 has expanded through acquisitions of smaller competitors and complementary businesses.
Primary Source Grounding & Direct Attribution
Direct Origin Attribution
Primary Reporting: techcrunch•Published: May 28, 2026
Original Coverage Title: “H1 secures $40M from CVS, proving SaaS startups can still attract investment”

Related Market Signals & Shifts

Recent verified developments and strategic activity across this market segment.

Health / AIOct 7, 2026

Healthleap Raises $38M for AI-Powered Hospital Patient Screening

Healthleap, a startup using AI to analyze patient records, has raised $38 million in seed and Series A funding. The round includes an $8 million seed co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures. The platform, deployed in over 50 hospitals, screens patients for conditions like malnutrition and delirium by extracting clinical concepts from clinician notes. Customers include Penn Medicine, Cedars-Sinai, and others. Revenue has grown over 10x in the past year. Funding will support expansion into more health conditions and outpatient care.

Read assessment
AI in HealthcareSep 22, 2026

Health AI Startup Heidi Raises $340M at $900M Valuation

Australian health AI startup Heidi has closed a Series C round of $100 million, led by Blackbird, with participation from Phoenix Court, Point72 Private Investments, and Headline, valuing the company at $900 million. In parallel, Heidi secured $240 million in growth financing from General Catalyst's Customer Value Fund, a revenue-based instrument that covers sales and customer acquisition costs. Combined, these deals provide $340 million in fresh capital. The company has raised $436.6 million to date. Heidi, founded in Melbourne, started as an AI scribe for clinical documentation and now positions itself as an 'AI care partner'. It reports 2.8 million patient encounters per week across 190 countries. The funding will support regulatory work for advanced clinical features in Europe and the UK, and expansion in the DACH region.

Read assessment
Investment in HealthTechOct 6, 2026

a16z Leads $120M Series B in General Medicine

Andreessen Horowitz (a16z) announced it is leading a $120 million Series B funding round for General Medicine, a healthcare technology company founded by the PillPack team. General Medicine aims to create a comprehensive healthcare shopping experience by combining patient history, clinical guidance, transparent pricing, and access to care into a single platform. The company operates its own medical group alongside a marketplace of external clinicians, offering a catalog of over 2,900 health products and services. The funding will support building out the consumer offering and enterprise partnerships with health systems, payors, and pharmacies. This marks a significant investment in transforming the healthcare experience using technology.

Read assessment
Executive Briefing & Watchlist

Receive all future signals for TechCrunch & competitors in your briefing

Never miss material M&A deals, leadership changes, account wins, or product rollouts. Polaris7 monitors 20,000+ primary sources 24/7, delivering verified telemetry directly into your executive briefing.

Daily primary source scansCurated executive briefingsUnsubscribe anytime